Skip to content

High Volume Caudal Study

Effect of Clonidine on High Volume-Low Concentration Caudals

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04263064
Enrollment
129
Registered
2020-02-10
Start date
2020-03-06
Completion date
2022-08-19
Last updated
2023-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Male Circumcision

Brief summary

The primary objective is to evaluate the effect of clonidine on the duration of analgesia provided by a high volume-low concentration caudal block for pediatric aurgical procedres. In addition, caudal clonidine's effect on length of recovery and post-operative emergence agitation will be measured.

Interventions

DRUGHigh Volume-Low Concentration without Clonidine

The control for this study will be a High Volume-Low Concentration (1.5cc/kg of 0.15% ropivacaine and 5mcg/cc epinephrine) caudal block

DRUGHigh Volume-Low Concentration with clonidine

The study intervention will be High Volume-Low Concentration with clonidine (1.5cc/kg of 0.15% ropivacaine, with 1mcg/cc of clonidine and 5mcg/cc epinephrine).

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

Outcome assessor and patient blinded to the medications in the block that the patient receives.

Intervention model description

Prospective, randomized, observer blinded study will attempt to determine if there is any benefit to the addition of clonidine to a HVLC caudal block, both in duration of analgesia and occurrence of emergence agitation.

Eligibility

Sex/Gender
MALE
Age
0 Years to 3 Years
Healthy volunteers
Yes

Inclusion criteria

* 3 years old or less * Weight \<= 13.3kg * American Society of Anesthesiology Physical Status (ASA) 1 or 2 * Undergoing circumcision surgery * Patients whose plan of care includes caudal block

Exclusion criteria

* Known allergy to clonidine, epinephrine, or amide local anesthetics * Inability or unwillingness of parent or legal guardian to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Presence of Pain24 hoursThe effect of clonidine on the duration of the analgesia provided by a high volume-low concentration caudal will be measured in the Post Anesthesia Care Unit pain assessments using CHEOPS score every at 0, 30, 60, and 90 minutes after arrival to PACU. The CHEOPS pain score tool is an observational scale for measuring postoperative pain in children aged 1-7 yrs. The tool includes six categories of pain behavior, each with 3-4 levels and scores range from 4 points (no pain) to 13 points (the worst pain).
Administration of Rescue Pain Medications24 hoursData will be collected and analyzed on the need for rescue pain medications by collecting doses of opioids administered the Post Anesthesia Care Unit.
Time to first Administration of Acetaminophen24 hours24 hours after discharge a phone call interview will be conducted to obtain the time of the first dose of acetaminophen

Secondary

MeasureTime frameDescription
Hemodynamic Changes24 hoursA change of greater than 20% in heart rate or blood pressure from their baseline established in the preoperative area
Average Time to Discharge24 hourstime of arrival to PACU and discharge time
Incidence of Emergence Delirium24 hoursThe incidence of emergence delirium will be collected utilizing the PAED Scale at 0, 30, 60, and 90 minutes after arrival to the Post Anesthesia Care Unit. The PAED scale will measure the presence of delirium by scoring behaviors from 1-4 (1=calm, 2=not calm but consolable, 3=moderately agitate, restless or not easily calmed, 4=combative, excited, thrashing around)
Sedation Levels24 hoursMeasured in PACU utilizing Ramsay Sedation Scale at 0, 30, 60, and 90 minutes after arrival in PACU. The Ramsay sedation scale is a scoring of responses (1-6) \[1=anxious or restless, 2=cooperative, oriented, tranquil, 3=responding to commands, 4=brisk response to stimulus, 5=sluggish response to stimulus, 6=no response to stimulus\].

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026